Qianliening capsule treats benign prostatic hyperplasia (BPH) by down-regulating the expression of PCNA, CyclinD1 and CDK4

Xiaoyong Zhong; Jiumao Lin; Jianheng Zhou; Wei Xu; Zhenfeng Hong; Jun Peng

doi:10.5897/AJB11.4078

African Journal of
Biotechnology

Abbreviation: Afr. J. Biotechnol.
Language: English
ISSN: 1684-5315
DOI: 10.5897/AJB
Start Year: 2002
Published Articles: 12452

Full Length Research Paper

Qianliening capsule treats benign prostatic hyperplasia (BPH) by down-regulating the expression of PCNA, CyclinD1 and CDK4

Xiaoyong Zhong1, Jiumao Lin1,2, Jianheng Zhou3, Wei Xu4, Zhenfeng Hong1* and Jun Peng1,2

1Academy of Integrative Medicine Biomedical Research Center, Fujian University of Traditional Chinese Medicine, 1 Huatuo Road, Minhou Shangjie, Fuzhou, Fujian 350108, China. 2Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine, 1 Huatuo Road, Minhou Shangjie, Fuzhou, Fujian 350108, China. 3Department of Integrative Medicine, Fujian University of Traditional Chinese Medicine, 1 Huatuo Road, Minhou Shangjie, Fuzhou, Fujian 350108, China. 4Department of Pharmacology, Fujian University of Traditional Chinese Medicine, 1 Huatuo Road, Minhou Shangjie, Fuzhou, Fujian 350108, China.
Email: [email protected]

Article Number - 68DE46A34109
Vol.11(30), pp. 7731-7737 , April 2012
https://doi.org/10.5897/AJB11.4078

Accepted: 08 March 2012
Published: 12 April 2012

Copyright © 2023 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0.